No. 0001 PGmatrixTM Enables Physiologically Relevant 3D Tumor Organoids

Overview Tumor organoid models are vital tools for drug discovery and development, and for translational cancer research. Conventional 2D or…

No. 0002 PGmatrixTM Enables 3D hiPSC Maintenance, Expansion, and Bioprinting

Overview Human induced pluripotent stem cells (hiPSCs) are fundamental to regenerative medicine, drug discovery, and disease modeling. Conventional 2D culture…

No. 0003 PGmatrixTM Cells Enables Lumen Cyst Formation within MDCK Organoids

Introduction Madin-Darby Canine Kidney (MDCK) cells are a widely used epithelial cell line in biomedical research and biotechnology due to…

No. 0004 PGmatrix™ Injection for Regenerative Medicine

Overview PGmatrix™ Injection in vivo delivery systems are transforming regenerative medicine by providing localized, sustained, and physiologically relevant environments for…